Proposed Legislation Would Mandate Medicaid Coverage for Ovulation Enhancing Drugs and Infertility Treatment



Senate Bill 3733, introduced in the New Jersey Senate and General Assembly on March 20, 2023, would require Medicaid to cover the cost of medically necessary ovulation-enhancing drugs and associated medical services for individuals aged 21 to 44 experiencing infertility, subject to federal financial participation. Coverage for ovulation-enhancing drugs and medical services would be limited to three treatment cycles per beneficiary’s lifetime.

Click Here to read the entire May 2023 Healthcare Law Update now!

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 |
Edward Hilzenrath | 973.403.3114 |
Vanessa Coleman | 973.364.5208 |

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Related Practices:   Healthcare Law

Related Industry:   Healthcare